首页|期刊导航|中华医学杂志(英文版)|Oncogenic β-catenin-driven liver cancer is susceptible to methotrexate-mediated disruption of nucleotide synthesis
Oncogenic β-catenin-driven liver cancer is susceptible to methotrexate-mediated disruption of nucleotide synthesis
Fangming Liu Liang Zheng Xiaochen Gai Hongbing Zhang Yuting Wu Baohui Zhang Shuhui Yang Kezhuo Shang Jie Li Pengju Zhang Weiwei Deng Linlin Chen
中华医学杂志(英文版)2024,Vol.137Issue(2):181-189,9.
中华医学杂志(英文版)2024,Vol.137Issue(2):181-189,9.DOI:10.1097/CM9.0000000000002816
Oncogenic β-catenin-driven liver cancer is susceptible to methotrexate-mediated disruption of nucleotide synthesis
Oncogenic β-catenin-driven liver cancer is susceptible to methotrexate-mediated disruption of nucleotide synthesis
摘要
关键词
Liver cancer/p-catenin/Methotrexate/Nucleotide synthesis/ChemotherapyKey words
Liver cancer/p-catenin/Methotrexate/Nucleotide synthesis/Chemotherapy引用本文复制引用
Fangming Liu,Liang Zheng,Xiaochen Gai,Hongbing Zhang,Yuting Wu,Baohui Zhang,Shuhui Yang,Kezhuo Shang,Jie Li,Pengju Zhang,Weiwei Deng,Linlin Chen..Oncogenic β-catenin-driven liver cancer is susceptible to methotrexate-mediated disruption of nucleotide synthesis[J].中华医学杂志(英文版),2024,137(2):181-189,9.基金项目
This work was supported by grants from the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences(No.2021-1-I2M-018),the Haihe Laboratory of Cell Ecosystem Innovation Fund(No.22HHXBSS00012),and the National Natural Science Foundation of China(Nos.81730078 and 81872287). (No.2021-1-I2M-018)